These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

473 related items for PubMed ID: 16494849

  • 1. Antibacterial drug discovery--then, now and the genomics future.
    Monaghan RL, Barrett JF.
    Biochem Pharmacol; 2006 Mar 30; 71(7):901-9. PubMed ID: 16494849
    [Abstract] [Full Text] [Related]

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 30; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 3. When will the genomics investment pay off for antibacterial discovery?
    Mills SD.
    Biochem Pharmacol; 2006 Mar 30; 71(7):1096-102. PubMed ID: 16387281
    [Abstract] [Full Text] [Related]

  • 4. Small and lethal: searching for new antibacterial compounds with novel modes of action.
    Pathania R, Brown ED.
    Biochem Cell Biol; 2008 Apr 30; 86(2):111-5. PubMed ID: 18443624
    [Abstract] [Full Text] [Related]

  • 5. Antibacterial drug discovery in the 21st century.
    Bush K.
    Clin Microbiol Infect; 2004 Nov 30; 10 Suppl 4():10-7. PubMed ID: 15522035
    [Abstract] [Full Text] [Related]

  • 6. Genetic strategies for antibacterial drug discovery.
    Miesel L, Greene J, Black TA.
    Nat Rev Genet; 2003 Jun 30; 4(6):442-56. PubMed ID: 12776214
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial drug development--the past, the present, and the future.
    Powers JH.
    Clin Microbiol Infect; 2004 Nov 30; 10 Suppl 4():23-31. PubMed ID: 15522037
    [Abstract] [Full Text] [Related]

  • 8. Exploiting genomics, genetics and chemistry to combat antibiotic resistance.
    Hughes D.
    Nat Rev Genet; 2003 Jun 30; 4(6):432-41. PubMed ID: 12776213
    [Abstract] [Full Text] [Related]

  • 9. Functional genomics in antibacterial drug discovery.
    Freiberg C, Brötz-Oesterhelt H.
    Drug Discov Today; 2005 Jul 01; 10(13):927-35. PubMed ID: 15993812
    [Abstract] [Full Text] [Related]

  • 10. Antibacterial discovery and development--the failure of success?
    Fernandes P.
    Nat Biotechnol; 2006 Dec 01; 24(12):1497-503. PubMed ID: 17160049
    [Abstract] [Full Text] [Related]

  • 11. Challenges of antibacterial discovery revisited.
    Gwynn MN, Portnoy A, Rittenhouse SF, Payne DJ.
    Ann N Y Acad Sci; 2010 Dec 01; 1213():5-19. PubMed ID: 21058956
    [Abstract] [Full Text] [Related]

  • 12. Genomic approaches to antibacterial discovery.
    Payne DJ, Gwynn MN, Holmes DJ, Rosenberg M.
    Methods Mol Biol; 2004 Dec 01; 266():231-59. PubMed ID: 15148422
    [Abstract] [Full Text] [Related]

  • 13. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ, Bradford PA.
    Curr Opin Microbiol; 2007 Oct 01; 10(5):441-6. PubMed ID: 17950658
    [Abstract] [Full Text] [Related]

  • 14. Cell-division inhibitors: new insights for future antibiotics.
    Lock RL, Harry EJ.
    Nat Rev Drug Discov; 2008 Apr 01; 7(4):324-38. PubMed ID: 18323848
    [Abstract] [Full Text] [Related]

  • 15. Use of genomics to select antibacterial targets.
    Pucci MJ.
    Biochem Pharmacol; 2006 Mar 30; 71(7):1066-72. PubMed ID: 16412986
    [Abstract] [Full Text] [Related]

  • 16. Conclusions: the future of antimicrobial therapy - Augmentin and beyond.
    Ball P.
    Int J Antimicrob Agents; 2007 Dec 30; 30 Suppl 2():S139-41. PubMed ID: 18029150
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Bacterial targets to antimicrobial leads and development candidates.
    Rogers BL.
    Curr Opin Drug Discov Devel; 2004 Mar 30; 7(2):211-22. PubMed ID: 15603255
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.